Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company imports and sells medicines.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 3,727 | 4,758 | 5,357 | 5,763 | 6,231 | 5,290 | 5,456 | +6.6% | |
| Total Non-Current Assets | 333 | 336 | 338 | 1,254 | 1,390 | 1,588 | 1,610 | +30.0% |
| TOTAL ASSETS | 4,061 | 5,094 | 5,696 | 7,017 | 7,621 | 6,878 | 7,066 | +9.7% |
| 522 | 1,566 | 1,317 | 1,947 | 865 | 223 | 759 | +6.4% | |
| 44 | 44 | 44 | 44 | 44 | 0 | 0 | nmf | |
| TOTAL LIABILITIES | 566 | 1,610 | 1,360 | 1,991 | 908 | 223 | 759 | +5.0% |
| Total Equity | 3,495 | 3,484 | 4,335 | 5,026 | 6,713 | 6,655 | 6,306 | +10.3% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 294 | 333 | 374 | 1,159 | 371 | 0 | 150 | -10.6% |
| Cash & Equivalents | 461 | 482 | 405 | 351 | 66 | 121 | 109 | -21.3% |
| Net Debt | 167 | 149 | 30 | 809 | 305 | 121 | 40 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →